{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:02:04Z","timestamp":1790262124814,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is characterized by aggressive behaviors, limited treatment options, and poor prognosis. Adipocytes, the predominant cellular component in the tumor microenvironment (TME) of breast cancer, interact bidirectionally with tumor cells, influencing tumor progression and immune evasion. Understanding the interactions between TNBC cells and adipocytes within TME is crucial for identifying new therapeutic targets. We employed murine models and co-culture systems to investigate the effects of adipocyte-TNBC cell interactions on lipid metabolism, signaling pathways, and immune evasion mechanisms. Our findings revealed that TNBC cells utilized PCSK9-enriched exosome transfer to induce the formation of cancer-associated adipocytes (CAAs) from adipocytes. These CAAs, characterized by altered lipid content and a pro-inflammatory secretory profile, contributed to a tumor-promoting environment. Additionally, CAAs enhanced the immune evasion properties of TNBC by modifying the metabolic pathways of tumor cells. In depth, CAAs induced fatty acid oxidation (FAO) in TNBC cells, which facilitated G3BP1-induced stabilization of PCSK9 and promoted OPTN-mediated autophagic degradation of the co-stimulatory molecules CD80 and CD86, which are essential for T cell activation. Our study identifies PCSK9 as a central mediator in the bidirectional interactions between TNBC cells and adipocytes, influencing tumor progression and immune evasion. These insights suggest that targeting the PCSK9 pathway could provide new therapeutic opportunities for TNBC, potentially transforming treatment approaches and improving patient outcomes. Further investigation into the mechanisms by which PCSK9 regulates these processes may yield novel combination strategies to enhance the efficacy of immunotherapy in TNBC.<\/jats:p>","DOI":"10.1038\/s41419-026-09027-y","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:09:07Z","timestamp":1783091347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Duanyang","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-5383","authenticated-orcid":false,"given":"Yawei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-0216","authenticated-orcid":false,"given":"Shaoquan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-0055","authenticated-orcid":false,"given":"Jihong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-3306","authenticated-orcid":false,"given":"Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"9027_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938\u201348.","journal-title":"N Engl J Med"},{"key":"9027_CR2","first-page":"93","volume":"8","author":"J Collignon","year":"2016","unstructured":"Collignon J, Lousberg L, Schroeder H, Jerusalem G. Triple-negative breast cancer: treatment challenges and solutions. Breast cancer (Dove Med Press). 2016;8:93\u2013107.","journal-title":"Breast cancer (Dove Med Press)"},{"key":"9027_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"9027_CR4","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","volume":"379","author":"P Schmid","year":"2018","unstructured":"Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med. 2018;379:2108\u201321.","journal-title":"N Engl J Med"},{"key":"9027_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","volume":"396","author":"J Cortes","year":"2020","unstructured":"Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet (Lond, Engl). 2020;396:1817\u201328.","journal-title":"Lancet (Lond, Engl)"},{"key":"9027_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382:810\u201321.","journal-title":"N Engl J Med"},{"key":"9027_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","volume":"17","author":"JD Martin","year":"2020","unstructured":"Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17:251\u201366.","journal-title":"Nat Rev Clin Oncol"},{"key":"9027_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239\u201352.","journal-title":"Nat Rev Cancer"},{"key":"9027_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"9027_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMcibr1914890","volume":"382","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ. Tumor microenvironment, metabolism, and immunotherapy. N Engl J Med. 2020;382:869\u201371.","journal-title":"N Engl J Med"},{"key":"9027_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"9027_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"9027_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","volume":"54","author":"E Danenberg","year":"2022","unstructured":"Danenberg E, Bardwell H, Zanotelli VRT, Provenzano E, Chin SF, Rueda OM, et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat Genet. 2022;54:660\u20139.","journal-title":"Nat Genet"},{"key":"9027_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48179-3","volume":"15","author":"Y Song","year":"2024","unstructured":"Song Y, Na H, Lee SE, Kim YM, Moon J, Nam TW, et al. Dysfunctional adipocytes promote tumor progression through YAP\/TAZ-dependent cancer-associated adipocyte transformation. Nat Commun. 2024;15:4052.","journal-title":"Nat Commun"},{"key":"9027_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1126\/science.1067431","volume":"296","author":"BS Wiseman","year":"2002","unstructured":"Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science (N Y, NY). 2002;296:1046\u20139.","journal-title":"Science (N Y, NY)"},{"key":"9027_CR16","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455\u201365.","journal-title":"Cancer Res"},{"key":"9027_CR17","doi-asserted-by":"publisher","first-page":"111362","DOI":"10.1016\/j.celrep.2022.111362","volume":"40","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhu Y, Hepler C, Zhang Q, Park J, Gliniak C, et al. Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep. 2022;40:111362.","journal-title":"Cell Rep"},{"key":"9027_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plipres.2017.11.002","volume":"69","author":"J Choi","year":"2018","unstructured":"Choi J, Cha YJ, Koo JS. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog Lipid Res. 2018;69:11\u201320.","journal-title":"Prog Lipid Res"},{"key":"9027_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","volume":"12","author":"Q Wu","year":"2019","unstructured":"Wu Q, Li B, Li Z, Li J, Sun S, Sun S. Cancer-associated adipocytes: key players in breast cancer progression. J Hematol Oncol. 2019;12:95.","journal-title":"J Hematol Oncol"},{"key":"9027_CR20","doi-asserted-by":"publisher","first-page":"33295","DOI":"10.1073\/pnas.2005950117","volume":"117","author":"Y Gao","year":"2020","unstructured":"Gao Y, Chen X, He Q, Gimple RC, Liao Y, Wang L, et al. Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin. Proc Natl Acad Sci USA. 2020;117:33295\u2013304.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9027_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s42255-023-00879-8","volume":"5","author":"A Mukherjee","year":"2023","unstructured":"Mukherjee A, Bezwada D, Greco F, Zandbergen M, Shen T, Chiang CY, et al. Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis. Nat Metab. 2023;5:1563\u201377.","journal-title":"Nat Metab"},{"key":"9027_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.trecan.2018.03.004","volume":"4","author":"E Lengyel","year":"2018","unstructured":"Lengyel E, Makowski L, DiGiovanni J, Kolonin MG. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends cancer. 2018;4:374\u201384.","journal-title":"Trends cancer"},{"key":"9027_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-016-0163-7","volume":"5","author":"S Balaban","year":"2017","unstructured":"Balaban S, Shearer RF, Lee LS, van Geldermalsen M, Schreuder M, Shtein HC, et al. Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab. 2017;5:1.","journal-title":"Cancer Metab"},{"key":"9027_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00324-7","volume":"7","author":"J Gyamfi","year":"2021","unstructured":"Gyamfi J, Yeo JH, Kwon D, Min BS, Cha YJ, Koo JS, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129.","journal-title":"NPJ Breast Cancer"},{"key":"9027_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang R, Wang Z, Hong J, Wu J, Huang O, He J, et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 2023;14:703.","journal-title":"Cell Death Dis"},{"key":"9027_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00257-6","volume":"9","author":"Q Wu","year":"2021","unstructured":"Wu Q, Li B, Li J, Sun S, Yuan J, Sun S. Cancer-associated adipocytes as immunomodulators in cancer. Biomark Res. 2021;9:2.","journal-title":"Biomark Res"},{"key":"9027_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","volume":"31","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T, et al. STAT3 activation-induced fatty acid oxidation in CD8(\u2009+\u2009) T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 2020;31:148\u201361.e5.","journal-title":"Cell Metab"},{"key":"9027_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","volume":"29","author":"M Ewertz","year":"2011","unstructured":"Ewertz M, Jensen MB, Gunnarsd\u00f3ttir K, H\u00f8jris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol : J Am Soc Clin Oncol. 2011;29:25\u201331.","journal-title":"J Clin Oncol : J Am Soc Clin Oncol"},{"key":"9027_CR29","doi-asserted-by":"crossref","unstructured":"Kothari C, Diorio C, Durocher F. The importance of breast adipose tissue in breast cancer. Int J Mol Sci. 2020;21:5760.","DOI":"10.3390\/ijms21165760"},{"key":"9027_CR30","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, Catozzi A, Garc\u00eda-Ca\u00f1averas JC, Gassaway BM, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183:1848\u201366.e26.","journal-title":"Cell"},{"key":"9027_CR31","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol : J Am Soc Clin Oncol. 2016;34:4270\u20136.","journal-title":"J Clin Oncol : J Am Soc Clin Oncol"},{"key":"9027_CR32","doi-asserted-by":"crossref","unstructured":"Hauser S, Sommerfeld P, Wodtke J, Hauser C, Schlitterlau P, Pietzsch J, et al. Application of a fluorescence anisotropy-based assay to quantify transglutaminase 2 activity in cell lysates. Int J Mol Sci. 2022;23:4475.","DOI":"10.3390\/ijms23094475"},{"key":"9027_CR33","first-page":"n1119","volume":"373","author":"G Iacobucci","year":"2021","unstructured":"Iacobucci G. Sixty seconds on \u2026 concussion in football. BMJ (Clin Res ed). 2021;373:n1119.","journal-title":"BMJ (Clin Res ed)"},{"key":"9027_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2019.06.012","volume":"460","author":"HX Wang","year":"2019","unstructured":"Wang HX, Gires O. Tumor-derived extracellular vesicles in breast cancer: from bench to bedside. Cancer Lett. 2019;460:54\u201364.","journal-title":"Cancer Lett"},{"key":"9027_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15:617\u201338.","journal-title":"Nat Rev Clin Oncol"},{"key":"9027_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10120-6","volume":"22","author":"E Wong Chong","year":"2022","unstructured":"Wong Chong E, Joncas FH, Seidah NG, Calon F, Diorio C, Gangloff A. Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers. BMC cancer. 2022;22:1049.","journal-title":"BMC cancer"},{"key":"9027_CR37","doi-asserted-by":"publisher","first-page":"111194","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang H, Meng J, Guo F, Ren D, Wu H, et al. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep. 2022;40:111194.","journal-title":"Cell Rep"},{"key":"9027_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31663-z","volume":"13","author":"CC Wong","year":"2022","unstructured":"Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, et al. The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC\/KRAS-mutant colorectal cancer. Nat Commun. 2022;13:3971.","journal-title":"Nat Commun"},{"key":"9027_CR39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1593\/neo.121252","volume":"14","author":"X Sun","year":"2012","unstructured":"Sun X, Essalmani R, Day R, Khatib AM, Seidah NG, Prat A. Proprotein convertase subtilisin\/kexin type 9 deficiency reduces melanoma metastasis in liver. Neoplasia (N Y, NY). 2012;14:1122\u201331.","journal-title":"Neoplasia (N Y, NY)"},{"key":"9027_CR40","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.neo.2021.07.007","volume":"23","author":"JM Suh","year":"2021","unstructured":"Suh JM, Son Y, Yoo JY, Goh Y, Seidah NG, Lee S, et al. Proprotein convertase subtilisin\/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells. Neoplasia (N Y, NY). 2021;23:993\u20131001.","journal-title":"Neoplasia (N Y, NY)"},{"key":"9027_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah NG, Prat A. The multifaceted biology of PCSK9. Endocr Rev. 2022;43:558\u201382.","journal-title":"Endocr Rev"},{"key":"9027_CR42","doi-asserted-by":"publisher","first-page":"e1003988","DOI":"10.1371\/journal.pmed.1003988","volume":"20","author":"S Fang","year":"2023","unstructured":"Fang S, Yarmolinsky J, Gill D, Bull CJ, Perks CM, Davey Smith G, et al. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. PLoS Med. 2023;20:e1003988.","journal-title":"PLoS Med"},{"key":"9027_CR43","doi-asserted-by":"publisher","first-page":"111758","DOI":"10.1016\/j.biopha.2021.111758","volume":"140","author":"K Mahboobnia","year":"2021","unstructured":"Mahboobnia K, Pirro M, Marini E, Grignani F, Bezsonov EE, Jamialahmadi T, et al. PCSK9 and cancer: rethinking the link. Biomed Pharmacother. 2021;140:111758.","journal-title":"Biomed Pharmacother"},{"key":"9027_CR44","doi-asserted-by":"publisher","first-page":"175721","DOI":"10.1016\/j.ejphar.2023.175721","volume":"949","author":"PP Oza","year":"2023","unstructured":"Oza PP, Kashfi K. The evolving landscape of PCSK9 inhibition in cancer. Eur J Pharm. 2023;949:175721.","journal-title":"Eur J Pharm"},{"key":"9027_CR45","doi-asserted-by":"publisher","first-page":"106916","DOI":"10.1016\/j.isci.2023.106916","volume":"26","author":"QC Yang","year":"2023","unstructured":"Yang QC, Wang S, Liu YT, Song A, Wu ZZ, Wan SC, et al. Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer. iScience. 2023;26:106916.","journal-title":"iScience"},{"key":"9027_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tibs.2020.11.001","volume":"46","author":"L Dumas","year":"2021","unstructured":"Dumas L, Herviou P, Dassi E, Cammas A, Millevoi S. G-quadruplexes in RNA biology: recent advances and future directions. Trends Biochem Sci. 2021;46:270\u201383.","journal-title":"Trends Biochem Sci"},{"key":"9027_CR47","first-page":"1584","volume":"45","author":"A Cammas","year":"2017","unstructured":"Cammas A, Millevoi S. RNA G-quadruplexes: emerging mechanisms in disease. Nucleic Acids Res. 2017;45:1584\u201395.","journal-title":"Nucleic Acids Res"},{"key":"9027_CR48","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tcb.2024.01.005","volume":"34","author":"P Kharel","year":"2024","unstructured":"Kharel P, Ivanov P. RNA G-quadruplexes and stress: emerging mechanisms and functions. Trends Cell Biol. 2024;34:771\u201384.","journal-title":"Trends Cell Biol"},{"key":"9027_CR49","doi-asserted-by":"publisher","first-page":"11323","DOI":"10.1093\/nar\/gkab873","volume":"49","author":"X He","year":"2021","unstructured":"He X, Yuan J, Wang Y. G3BP1 binds to guanine quadruplexes in mRNAs to modulate their stabilities. Nucleic Acids Res. 2021;49:11323\u201336.","journal-title":"Nucleic Acids Res"},{"key":"9027_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022;13:1511.","journal-title":"Nat Commun"},{"key":"9027_CR51","first-page":"2080","volume":"27","author":"N Noma","year":"2012","unstructured":"Noma N, Simizu S, Kambayashi Y, Kabe Y, Suematsu M, Umezawa K. Involvement of NF-\u03baB-mediated expression of galectin-3-binding protein in TNF-\u03b1-induced breast cancer cell adhesion. Oncol Rep. 2012;27:2080\u20134.","journal-title":"Oncol Rep"},{"key":"9027_CR52","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.molcel.2016.06.029","volume":"63","author":"A Castello","year":"2016","unstructured":"Castello A, Fischer B, Frese CK, Horos R, Alleaume AM, Foehr S, et al. Comprehensive identification of RNA-binding domains in human cells. Mol cell. 2016;63:696\u2013710.","journal-title":"Mol cell"},{"key":"9027_CR53","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-23-0505","volume":"83","author":"C Bouche","year":"2023","unstructured":"Bouche C, Quail DF. Fueling the tumor microenvironment with cancer-associated adipocytes. Cancer Res. 2023;83:1170\u20132.","journal-title":"Cancer Res"},{"key":"9027_CR54","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","volume":"588","author":"X Liu","year":"2020","unstructured":"Liu X, Bao X, Hu M, Chang H, Jiao M, Cheng J, et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 2020;588:693\u20138.","journal-title":"Nature"},{"key":"9027_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-022-02584-y","volume":"42","author":"Y Gu","year":"2023","unstructured":"Gu Y, Lin X, Dong Y, Wood G, Seidah NG, Werstuck G, et al. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. J Exp Clin cancer Res : CR. 2023;42:2.","journal-title":"J Exp Clin cancer Res : CR"},{"key":"9027_CR56","doi-asserted-by":"publisher","first-page":"1142428","DOI":"10.3389\/fimmu.2023.1142428","volume":"14","author":"X Gao","year":"2023","unstructured":"Gao X, Yi L, Jiang C, Li S, Wang X, Yang B, et al. PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer. Front Immunol. 2023;14:1142428.","journal-title":"Front Immunol"},{"key":"9027_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12148-2","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang X, Zhang Y, Shi T, Zhang Y, Song X, et al. Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy. BMC cancer. 2024;24:445.","journal-title":"BMC cancer"},{"key":"9027_CR58","doi-asserted-by":"publisher","first-page":"947756","DOI":"10.3389\/fimmu.2022.947756","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Liu H, He P, An D, Guo X, Zhang X, et al. Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8(\u2009+\u2009) T cells and the exclusion of Treg cells. Front Immunol. 2022;13:947756.","journal-title":"Front Immunol"},{"key":"9027_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41573-020-00208-8","volume":"20","author":"S Crunkhorn","year":"2021","unstructured":"Crunkhorn S. Blocking PCSK9 enhances immune checkpoint therapy. Nat Rev Drug Discov. 2021;20:20.","journal-title":"Nat Rev Drug Discov"},{"key":"9027_CR60","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1164\/ajrccm.162.supplement_3.15tac5","volume":"162","author":"L Bugeon","year":"2000","unstructured":"Bugeon L, Dallman MJ. Costimulation of T cells. Am J Respir Crit Care Med. 2000;162:S164\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"9027_CR61","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2009.03.007","volume":"136","author":"S Rahighi","year":"2009","unstructured":"Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell. 2009;136:1098\u2013109.","journal-title":"Cell"},{"key":"9027_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/15548627.2017.1391970","volume":"14","author":"F Li","year":"2018","unstructured":"Li F, Xu D, Wang Y, Zhou Z, Liu J, Hu S, et al. Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy. 2018;14:66\u201379.","journal-title":"Autophagy"},{"key":"9027_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12708","volume":"7","author":"F Li","year":"2016","unstructured":"Li F, Xie X, Wang Y, Liu J, Cheng X, Guo Y, et al. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat Commun. 2016;7:12708.","journal-title":"Nat Commun"},{"key":"9027_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13718-w","volume":"10","author":"Z You","year":"2019","unstructured":"You Z, Jiang WX, Qin LY, Gong Z, Wan W, Li J, et al. Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress. Nat Commun. 2019;10:5792.","journal-title":"Nat Commun"},{"key":"9027_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15548627.2022.2062112","volume":"19","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wan W. Acetylation in the regulation of autophagy. Autophagy. 2023;19:379\u201387.","journal-title":"Autophagy"},{"key":"9027_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27210-w","volume":"8","author":"A Nickel","year":"2018","unstructured":"Nickel A, Bl\u00fccher C, Kadri OA, Schwagarus N, M\u00fcller S, Schaab M, et al. Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells. Sci Rep. 2018;8:9482.","journal-title":"Sci Rep"},{"key":"9027_CR67","first-page":"468","volume":"26","author":"G Spaziante","year":"1966","unstructured":"Spaziante G. [The problem of noises in hospitals. I. Phonometric data in various environments and in various conditions]. Riv Ital d\u2019Ig. 1966;26:468\u2013511.","journal-title":"Riv Ital d\u2019Ig"},{"key":"9027_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6:263.","journal-title":"Signal Transduct Target Ther"},{"key":"9027_CR69","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"9027_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","volume":"11","author":"T Deng","year":"2016","unstructured":"Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016;11:421\u201349.","journal-title":"Annu Rev Pathol"},{"key":"9027_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"9027_CR72","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"9027_CR73","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34:1675\u201399.","journal-title":"Cell Metab"},{"key":"9027_CR74","doi-asserted-by":"crossref","unstructured":"Moraes JA, Encarna\u00e7\u00e3o C, Franco VA, Xavier Botelho LG, Rodrigues GP, Ramos-Andrade I, et al. Adipose tissue-derived extracellular vesicles and the tumor microenvironment: revisiting the hallmarks of cancer. Cancers. 2021;13:3328.","DOI":"10.3390\/cancers13133328"},{"key":"9027_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01932-0","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qin C, Dewanjee S, Bhattacharya H, Chakraborty P, Jha NK, et al. Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. Mol Cancer. 2024;23:18.","journal-title":"Mol Cancer"},{"key":"9027_CR76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-pathmechdis-031521-022116","volume":"18","author":"JW Clancy","year":"2023","unstructured":"Clancy JW, D\u2019Souza-Schorey C. Tumor-derived extracellular vesicles: multifunctional entities in the tumor microenvironment. Annu Rev Pathol. 2023;18:205\u201329.","journal-title":"Annu Rev Pathol"},{"key":"9027_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ccell.2018.12.006","volume":"35","author":"CM Kenific","year":"2019","unstructured":"Kenific CM, Wang G, Lyden D. Tumor extracellular vesicles impede interferon alert responses. Cancer Cell. 2019;35:3\u20135.","journal-title":"Cancer Cell"},{"key":"9027_CR78","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri R, McAndrews KM. The role of extracellular vesicles in cancer. Cell. 2023;186:1610\u201326.","journal-title":"Cell"},{"key":"9027_CR79","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348.","journal-title":"Cancer Cell"},{"key":"9027_CR80","doi-asserted-by":"crossref","unstructured":"Mei W, Faraj Tabrizi S, Godina C, Lovisa AF, Isaksson K, Jernstr\u00f6m H, et al. A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor. Cell. 2025;188:371\u201389.e28.","DOI":"10.1016\/j.cell.2024.11.009"},{"key":"9027_CR81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang L, Li S, Luo H, Lu Q, Yu S. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin cancer Res : CR. 2022;41:303.","journal-title":"J Exp Clin cancer Res : CR"},{"key":"9027_CR82","doi-asserted-by":"publisher","first-page":"609663","DOI":"10.3389\/fonc.2020.609663","volume":"10","author":"B Xu","year":"2020","unstructured":"Xu B, Li S, Fang Y, Zou Y, Song D, Zhang S, et al. Proprotein convertase subtilisin\/kexin type 9 promotes gastric cancer metastasis and suppresses apoptosis by facilitating MAPK signaling pathway through HSP70 up-regulation. Front Oncol. 2020;10:609663.","journal-title":"Front Oncol"},{"key":"9027_CR83","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41586-025-09017-8","volume":"643","author":"G Rademaker","year":"2025","unstructured":"Rademaker G, Hernandez GA, Seo Y, Dahal S, Miller-Phillips L, Li AL, et al. PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature. 2025;643:1381\u201390.","journal-title":"Nature"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09027-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09027-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09027-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:02:12Z","timestamp":1790258532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09027-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9027"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09027-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The procedures of this study were approved by Institutional Committee of the First Affiliated Hospital of Sun Yat-sen University.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Every participant signed informed consent prior to surgery.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"827"}}